New Actos Bladder Cancer Lawsuit Filed in Illinois
On November 4, 2011, Georgia resident Josephine Stodgill and her Actos lawyers filed an Actos lawsuit in the U.S. District Court in the Northern District of Illinois. Stodgill alleges that she developed Actos bladder cancer as a result of using the diabetes medication. Stodgill’s Actos lawyers are asking for more than $75,000 in compensatory and punitive damages from the manufacturer of the drug, Takeda America.
Reports of Actos bladder cancer continue to grow
A growing number of diabetes patients around the country who have been diagnosed with Actos bladder cancer are meeting with Actos lawyers for an Actos lawsuit evaluation. Bladder cancer is a serious disease that affects nearly 70,000 people in the United States every year. About 15,000 die from bladder cancer annually. As Actos lawyers will discuss with potential plaintiffs during an Actos lawsuit evaluation, patients who are diagnosed with Actos bladder cancer often have to undergo treatments like chemotherapy, which can result in additional debilitating side effects.
Actos lawyers conduct Actos lawsuit evaluation
In the complaint for her lawsuit, Stodgill and her Actos lawyers claim that she began taking Actos to treat type 2 diabetes in 2006 and continued to take the drug until September, 2011. An FDA warning from earlier this year states that the use of Actos for longer than 12 months could increase the risk of Actos bladder cancer.
Stodgill’s Actos lawyers also allege that Takeda “concealed their knowledge that Actos can cause bladder cancer,” and “did not adequately inform consumers” of the risk. They also state that Takeda “had a duty to warn of adverse drug reactions.”
Stodgill and her Actos lawyers claim that she continues to deal with pain and suffering from her cancer. According to her complaint, others who have been diagnosed with Actos bladder cancer also face ongoing medical issues. As a result of the manufacturer’s inactions in regard to warning the medical community and consumers about the risks associated with Actos, those who have taken the medication for more than 12 months continue to be endangered.
Stodgill’s Actos lawyers are claiming a number of causes of action in the complaint for her lawsuit, including negligence, failure to warn, breach of warranty and defective design.
No MDL for Actos bladder cancer lawsuits at this time
While many lawsuits have been filed by Actos lawyers to date, no decision has yet been reached to consolidate cases like the recent one in Illinois into a single court as part of multidistrict litigation (MDL). A determination on an Actos MDL is expected next month.
Like others who have participated in an Actos lawsuit evaluation after being injured by the diabetes drug, Stodgill is hoping that her Actos lawyers can help her obtain compensation for her injuries and medical bills. As more incidences of Actos bladder cancer, along with other side effects such as Actos heart failure, come to light, additional lawsuits are expected to be filed by Actos lawyers across the country.